Difference between revisions of "Porocarcinoma"
Jump to navigation
Jump to search
(create) |
|||
| Line 3: | Line 3: | ||
==General== | ==General== | ||
*Malignant counterpart of ''[[poroma]]''. | *Malignant counterpart of ''[[poroma]]''. | ||
*Very rare ~ most papers are case reports.<ref name=pmid25515648>{{Cite journal | last1 = Riera-Leal | first1 = L. | last2 = Guevara-Gutiérrez | first2 = E. | last3 = Barrientos-García | first3 = JG. | last4 = Madrigal-Kasem | first4 = R. | last5 = Briseño-Rodríguez | first5 = G. | last6 = Tlacuilo-Parra | first6 = A. | title = Eccrine porocarcinoma: epidemiologic and histopathologic characteristics. | journal = Int J Dermatol | volume = 54 | issue = 5 | pages = 580-6 | month = | year = 2015 | doi = 10.1111/ijd.12714 | PMID = 25515648 }}</ref> | |||
Clinical - based on meta-analysis of 453 cases: | Clinical - based on meta-analysis of 453 cases: | ||
*No predominance males versus females. | *No predominance males versus females. | ||
*Aggressive behaviour >30% of cases have metastases at presentation - typically to lymph nodes. | |||
Treatment: | |||
*Surgery, | |||
==Gross== | ==Gross== | ||
Revision as of 04:18, 6 June 2018
Porocarcinoma is a rare malignant skin tumour that has an aggressive behaviour.[1]
General
Clinical - based on meta-analysis of 453 cases:
- No predominance males versus females.
- Aggressive behaviour >30% of cases have metastases at presentation - typically to lymph nodes.
Treatment:
- Surgery,
Gross
- Mass or nodule - typically head and neck (40% of cases) or lower extremity (34% of cases).[1]
See also
References
- ↑ 1.0 1.1 Salih, AM.; Kakamad, FH.; Baba, HO.; Salih, RQ.; Hawbash, MR.; Mohammed, SH.; Othman, S.; Saeed, YA. et al. (Aug 2017). "Porocarcinoma; presentation and management, a meta-analysis of 453 cases.". Ann Med Surg (Lond) 20: 74-79. doi:10.1016/j.amsu.2017.06.027. PMID 28721214.
- ↑ Riera-Leal, L.; Guevara-Gutiérrez, E.; Barrientos-García, JG.; Madrigal-Kasem, R.; Briseño-Rodríguez, G.; Tlacuilo-Parra, A. (2015). "Eccrine porocarcinoma: epidemiologic and histopathologic characteristics.". Int J Dermatol 54 (5): 580-6. doi:10.1111/ijd.12714. PMID 25515648.